Zobrazeno 1 - 10 of 167 pro vyhledávání: '"William P. Castelli"'
2
Making practical sense of clinical trial data in decreasing cardiovascular risk
Autor: William P. Castelli
Publikováno v: The American Journal of Cardiology. 88:16-20
Clinical studies now affirm what epidemiologic evidence has long suggested-that a broad range of patients can benefit from lipid reduction, including those without overt coronary artery disease and only moderate lipid elevations. Together, these stud
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5efa975f8fff325375dd361ee9bbc0a9
https://doi.org/10.1016/s0002-9149(01)01872-0
Zobrazit plný text záznamu
3
Lipoproteins and Cardiovascular Disease: Biological Basis and Epidemiological Studies
Autor: William P. Castelli
Publikováno v: Value in Health. 1:105-109
There is a long history to our understanding of the biological basis of lipoproteins in cardiovascular disease and to the key epidemiological studies in this field. Building on a wealth of laboratory evidence explaining the role of cholesterol and li
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::965fedc83da3ee6a0205f23d64310718
https://doi.org/10.1046/j.1524-4733.1998.120105.x
Zobrazit plný text záznamu
4
Epidemiologic assessment of angina before and after myocardial infarction: The Framingham Study
Autor: William P. Castelli, Frederick N. Brand, Lawrence M. Friedman, William B. Kannel, Martin G. Larson
Publikováno v: American Heart Journal. 132:174-178
Angina pectoris before and after MI was evaluated in a sample of 729 men and women from a general population in whom MI developed during a 36-year period of follow-up. Relations of AP to subsequent CHD events and mortality after initial MI were analy
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09687f3a3ec636418fdfb02e96739449
https://doi.org/10.1016/s0002-8703(96)90406-8
Zobrazit plný text záznamu
5
Lipids, risk factors and ischaemic heart disease
Autor: William P. Castelli
Publikováno v: Atherosclerosis. 124:S1-S9
Over 200 risk factors for cardiovascular disease (CVD) have now been identified. Among these, the three most important are (1) abnormal lipids, including the fact that there are more than 15 types of cholesterol-containing lipoproteins and four diffe
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61f98c0d8ab521be3261c9dc2a87ee85
https://doi.org/10.1016/0021-9150(96)05851-0
Zobrazit plný text záznamu
6
A prospective investigation of elevated lipoprotein (a) detected by electrophoresis and cardiovascular disease in women. The Framingham Heart Study
Autor: Peter W.F. Wilson, Ernst J. Schaefer, L. A. Cupples, David R. Gagnon, Jose M. Ordovas, Andrew G. Bostom, William P. Castelli, Jennifer L. Jenner
Publikováno v: Circulation. 90:1688-1695
BACKGROUND Sinking prebeta lipoprotein is a putative marker for elevated levels of lipoprotein (a). Although prospective data suggest that increased plasma lipoprotein (a) is an independent risk factor for coronary heart disease in men, no prospectiv
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9afc80320e2b95c9e389c2a173982e77
https://doi.org/10.1161/01.cir.90.4.1688
Zobrazit plný text záznamu
7
Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study
Autor: William P. Castelli, Peter W.F. Wilson, Stefania Lamon-Fava, Ernst J. Schaefer, M M Schaefer, S. Johnson, Jose M. Ordovas
Publikováno v: Arteriosclerosis and Thrombosis: A Journal of Vascular Biology. 14:1105-1113
Apolipoprotein (apo) E phenotype is an important genetic determinant of plasma low-density lipoprotein (LDL) cholesterol and apo B levels. We have determined apo E phenotype by isoelectric focusing and plasma lipid, lipoprotein cholesterol, apo A-I,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c547a9197307794f343f94ac40f2f490
https://doi.org/10.1161/01.atv.14.7.1105
Zobrazit plný text záznamu
8
Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study
Autor: Stefania Lamon-Fava, Susan D. Cohn, Ernst J. Schaefer, Peter W.F. Wilson, M M Schaefer, William P. Castelli, Jose M. Ordovas
Publikováno v: Scopus-Elsevier
Journal of Lipid Research, Vol 35, Iss 5, Pp 871-882 (1994)
A decreased high density lipoprotein (HDL) cholesterol level (< 35 mg/dl) has been shown to be a significant independent risk factor for coronary heart disease (CHD). Moreover, increased HDL cholesterol levels (> or = 60 mg/dl) are associated with a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc9c6dfa3f6d86ec343f0cb2992226f3
https://doi.org/10.1016/s0022-2275(20)39181-1
Zobrazit plný text záznamu
10
The fact and fiction of lowering cholesterol in the primary prevention of coronary heart disease
Autor: William P Castelli
Publikováno v: Heart. 69:S70-S73
Throughout the campaigns to arrive at a national consensus on cholesterol lowering there has been a series of papers that try to discourage physicians from identifying high risk subjects. I will examine some of the issues that have been raised about
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2e2701bcb5dbc47fddae5c7b6c895e8b
https://doi.org/10.1136/hrt.69.1_suppl.s70
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje